Skip to main content
Tindara Franchina on Muck Rack

Tindara Franchina

As seen in: MDPI, Expert Review of Anticancer Therapy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Tindara

Contact Tindara, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The Challenging Scenario of Cancer Treatment for People with HIV: Clinical Experience with Immune Checkpoint Inhibitors

|
By Tindara Franchina, Ylenia Russotto, Patrizia Carroccio, Mariapia Marafioti
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System

|
By Giuseppe Cicala, Giulia Russo, Vincenza Cinzia Santoro, Tindara Franchina
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?

Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System

|
By Giuseppe Cicala, Giulia Russo, Vincenza Cinzia Santoro, Tindara Franchina
| preprints.org
Preprint Article Version 1 This version is not peer-reviewed Version 1 : Received: 20 September 2024 / Approved: 20 September 2024 / Online: 20 September 2024 (14:58:48 CEST) Cicala, G.; Russo, G.; Santoro, V.; Franchina, T.; Silvestris, N.; Santarpia, M.; Spina, E.; Barbieri, M. A. Neuropsychiatric Adverse Events with Monoclonal Antibodies Approved for Multiple Myeloma: An Analysis from the FDA Adverse Event Reporting System. Preprints 2024, 2024091651.
Open in Who Shared Issue with article?
See all 5 articles